Accelerating TIL Manufacturing Turnaround & Improving Safety with the FAST-TIL Platform

Time: 2:40 pm
day: Conference Day One PM

Details:

• Presenting a manufacturing platform, achieving 13-19-day turnaround with a closed system to enhance safety and consistency
• Highlighting Phase I clinical results showing strong efficacy and a favorable safety profile, with reduced lymphodepletion and IL-2 dosing
• Exploring how streamlined CMC processes support rapid, scalable, and patient-friendly TIL therapy delivery

Speakers:

Yi Zhao Yi Zhao is co-founder of Qingdao Sino-Cell Biomedicine. She oversees product development including R&D, CMC and clinical trial advancing. She is an inventor on multiple Read more